Institutional investors hold a majority ownership of MRK through the 75.60% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MANAGED ACCOUNT ADVISORS LLC Bought 7.0 Million shares of Merck
LSV ASSET MANAGEMENT Bought 4.9 Million shares of Merck
ORBIS INVESTMENT MANAGEMENT LTD. Bought 4.5 Million shares of Merck